Trove of Alzheimer’s patients’ molecular, clinical data available

289 views · Published 11 October 2016 · 2:28 · Indexed 14 November 2026

Channel: Mayo Clinic · 2016 · Science & Technology

Watch on YouTube

In what the National Institutes of Health (NIH) has described as a pioneering effort, a research team at Mayo Clinic’s campus in Jacksonville, Florida, has made public a treasure trove of data aimed at accelerating development of therapies for Alzheimer’s disease.

The data, a description of which is published in Nature Scientific Data, “implicates a number of genes that are likely to be involved in disease pathways, providing researchers with many testable hypotheses,” says the study’s senior investigator, neurologist and neuroscientist Nilufer Ertekin-Taner, M.D., Ph.D.

The study details whole-genome genotype and gene expression patterns on 2,655 individuals, including people with dementia and those without it. The data includes more than 842 million datapoints and clinical information that will enable researchers around the world to study what is different about Alzheimer’s brains and what can be done to prevent, treat or stop the disease, Dr. Ertekin-Taner says.

In this video, Dr. Mariet Allen, one of the researchers discusses the potential impact.

More from this channel